Resource Epstein-Barr virus vaccine elicits potent neutralizing antibodies in animals

Cort

Founder of Health Rising and Phoenix Rising
Staff member
Epstein-Barr virus vaccine elicits potent neutralizing antibodies in animals

First identified in 1964, EBV is one of the most common human viruses in the world, infecting nine out of 10 people at some point in their lives. Most people experience no illness or only mild symptoms. Most commonly spread through saliva, it is best known as the major cause of infectious mononucleosis, or mono.
Interesting. Sometimes vaccines can also help with current problems. In any case infectious mononucleosis is associated with an increased risk for MS and IM is becoming more common over time. Glad to see they're doing this.

Although it may not be possible to create a vaccine that completely prevents EBV infection, the authors note, clinical observations and results from clinical trials of an experimental EBV vaccine suggest that it may be possible to create an EBV vaccine capable of preventing the diseases that sometimes follow EBV infection.
 

Forum Tips

Support Our Work

DO IT MONTHLY

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Shopping on Amazon.com For HR

Latest Resources

Top